Attached files
| file | filename |
|---|---|
| EX-99 - INVACARE CORP | exhibit.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 15, 2010
|
INVACARE CORPORATION
|
|
__________________________________________________________________________________________
|
|
(Exact name of registrant as specified in its charter)
|
|
Ohio
|
1-15103
|
95-2680965
|
|
______________________________________________________________________________________________________________________________________________________
|
||
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
One Invacare Way, P.O. Box 4028, Elyria, Ohio
|
44036
|
|
____________________________________________________________
|
______________________________
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (440) 329-6000
|
__________________________________________________________________________________________
|
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01.
|
Other Events.
|
On October 15, 2010, Invacare Corporation (the “Company”) issued a press release announcing that it had extended the consent expiration relating to the Company’s cash tender offer and consent solicitation for any and all of its outstanding $146 million aggregate principal amount of 9 3/4% Senior Notes due 2015 (CUSIP No. 461203AB7). A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit Number
|
Description
|
|
99.1
|
Press Release, dated October 15, 2010.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Invacare Corporation
|
|
|
(Registrant)
|
|
|
Date: October 18, 2010
|
By: /s/ Robert K. Gudbranson
Robert K. Gudbranson
Senior Vice President and
Chief Financial Officer
|
Exhibit Index
|
Exhibit Number
|
Description
|
|
99.1
|
Press Release, dated October 15, 2010.
|